Medical Molecular Morphology

, Volume 42, Issue 3, pp 162–166

Morphometric analysis of regional lymph nodes in surgically resected non-small cell lung cancer

  • Hajimu Gotoh
  • Naoki Kanomata
  • Masahiro Yoshimura
  • Yoshiharu Ohno
  • Takuya Moriya
  • Chiho Ohbayashi
Original Paper

Abstract

Nodal staging is a crucial factor in choosing the treatment option for non-small cell lung cancer (NSCLC). However, so far as we know, a computer-based histomorphometric analysis of lymph nodes in NSCLC has never been developed. We studied 299 surgically resected lymph nodes from 108 patients with NSCLC. Microscopic digital images were analyzed with Scion Image software. Seventy lymph nodes had at least one metastatic focus. The metastasis occupancy area per node ranged from 0.01 to 209.58 mm2 (mean, 29.58 ± 5.87 mm2). The metastasis occupancy ratio ranged from 0.01% to 100% (mean, 48.70% ± 42.10%). The short-axis diameter of malignant lymph nodes was significantly longer than that of benign lymph nodes (P = 0.0002). The average metastasis occupancy area in the regional lymph nodes of NSCLC is quite small. Various inflammatory conditions can result in a false-positive diagnosis when these techniques are used. Studies that combine analysis of primary tumor size and serum carcinoembryonic antigen (CEA) levels with imaging methods should be considered. Finally, the use of mediastinoscopy or video-assisted thoracoscopic surgery is encouraged in determining the exact nodal status in NSCLC.

Key words

Morphometry Histomorphometry Non-small cell lung cancer Lymph node Staging NIH image Scion image Tumor occupancy area 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Rosell R, Gomez-Codina J, Camps C, Maestre J, Padille J, Canto A, Mate JL, Li S, Roig J, Olazabal A, Canela M, Ariza A, Skacel Z, Morera-Prat J, Abad A (1994) A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med 330: 153–158PubMedCrossRefGoogle Scholar
  2. 2.
    Ichinose Y, Kato H, Koike T, Tsuchiya R, Fujisawa T, Shimizu N, Watanabe Y, Mitsudomi T, Yoshimura M (2001) Overall survival and local recurrence of 406 completely resected stage IIIa-N2 non-small cell lung cancer patients: questionnaire survey of the Japan Clinical Oncology Group to plan for clinical trials. Lung Cancer 34:29–36PubMedCrossRefGoogle Scholar
  3. 3.
    Postmus PE, Rocmans P, Asamura H, Ball D, Belderbos J, Cappello M, Jassem J, Novello S, Pass H, Passlick B (2003) Consensus report IASLC workshop Bruges, September 2002: pretreatment minimal staging for non-small cell lung cancer. Lung Cancer 42:3–6CrossRefGoogle Scholar
  4. 4.
    Glazer GM, Gross BH, Quint LE, Francis IR, Bookstein FL, Orringer MB (1985) Normal mediastinal lymph nodes: number and size according to American Thoracic Society mapping. AJR Am J Roentgenol 144:261–265PubMedGoogle Scholar
  5. 5.
    Quint LE, Glazer GM, Orringer MB, Francis IR, Bookstein FL (1986) Mediastinal lymph node detection and sizing at CT and autopsy. AJR Am J Roentgenol 147:469–472PubMedGoogle Scholar
  6. 6.
    Webb WR, Gatsonis C, Zerhouni EA, Heelan RT, Glazer GM, Francis IR, McNeil BJ (1991) CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology 178:705–713PubMedGoogle Scholar
  7. 7.
    Lee N, Inoue K, Yamamoto R, Kinoshita H (1992) Patterns of internal echoes in lymph nodes in the diagnosis of lung cancer metastasis. World J Surg 16:986–993; discussion 993–994PubMedCrossRefGoogle Scholar
  8. 8.
    Kerr KM, Lamb D, Wathen CG, Walker WS, Douglas NJ (1992) Pathological assessment of mediastinal lymph nodes in lung cancer: implications for non-invasive mediastinal staging. Thorax 47:337–341PubMedCrossRefGoogle Scholar
  9. 9.
    McLoud TC, Bourgouin PM, Greenberg RW, Kosiuk JP, Templeton PA, Shepard JA, Moore EH, Wain JC, Mathisen DJ, Grillo HC (1992) Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 182:319–323PubMedGoogle Scholar
  10. 10.
    Arita T, Matsumoto T, Kuramitsu T, Kawamura M, Matsunaga N, Sugi K, Esato K (1996) Is it possible to differentiate malignant mediastinal nodes from benign nodes by size? Reevaluation by CT, transesophageal echocardiography, and nodal specimen. Chest 110:1004–1008PubMedCrossRefGoogle Scholar
  11. 11.
    Prenzel KL, Monig SP, Sinning JM, Baldus SE, Brochhagen HG, Schneider PM, Holscher AH (2003) Lymph node size and metastatic infiltration in non-small cell lung cancer. Chest 123:463–467PubMedCrossRefGoogle Scholar
  12. 12.
    Wahl RL, Quint LE, Greenough RL, Meyer CR, White RI, Orringer MB (1994) Staging of mediastinal non-small cell lung cancer with FDG-PET, CT, and fusion images: preliminary prospective evaluation. Radiology 191:371–377PubMedGoogle Scholar
  13. 13.
    Guhlmann A, Storck M, Kotzerke J, Moog F, Sunder-Plassmann L, Reske SN (1997) Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET). Thorax 52:438–441PubMedCrossRefGoogle Scholar
  14. 14.
    Boiselle PM, Patz EF Jr, Vining DJ, Weissleder R, Shepard JA, McLoud TC (1998) Imaging of mediastinal lymph nodes: CT, MR, and FDG-PET. Radiographics 18:1061–1069PubMedGoogle Scholar
  15. 15.
    Gupta NC, Graeber GM, Rogers JS II, Bishop HA (1999) Comparative efficacy of positron emission tomography with FDG and computed tomographic scanning in preoperative staging of non-small cell lung cancer. Ann Surg 229:286–291PubMedCrossRefGoogle Scholar
  16. 16.
    Gupta NC, Graeber GM, Bishop HA (2000) Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions. Chest 117:773–778PubMedCrossRefGoogle Scholar
  17. 17.
    Gould MK, Maclean CC, Kuschner WG, Rydzak CE, Owens DK (2001) Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 285:914–924PubMedCrossRefGoogle Scholar
  18. 18.
    Ohno Y, Sugimura K, Hatabu H (2002) MR imaging of lung cancer. Eur J Radiol 44:172–181PubMedCrossRefGoogle Scholar
  19. 19.
    Takenaka D, Ohno Y, Hatabu H, Ohbayashi C, Yoshimura M, Ohkita Y, Sugimura K (2002) Differentiation of metastatic versus non-metastatic mediastinal lymph nodes in patients with non-small cell lung cancer using respiratory-triggered short inversion time inversion recovery (STIR) turbo spin-echo MR imaging. Eur J Radiol 44:216–224PubMedCrossRefGoogle Scholar
  20. 20.
    Antoch G, Stattaus J, Nemat AT, Marnitz S, Beyer T, Kuehl H, Bockisch A, Debatin JF, Freudenberg LS (2003) Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology 229:526–533PubMedCrossRefGoogle Scholar
  21. 21.
    Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, von Schulthess GK, Steinert HC (2003) Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 348:2500–2507PubMedCrossRefGoogle Scholar
  22. 22.
    Vansteenkiste JF (2003) PET scan in the staging of non-small cell lung cancer. Lung Cancer 42:S27–S37PubMedCrossRefGoogle Scholar
  23. 23.
    Funatsu T, Matsubara Y, Ikeda S, Hatakenaka R, Hanawa T, Ishida H (1994) Preoperative mediastinoscopic assessment of N factors and the need for mediastinal lymph node dissection in T1 lung cancer. J Thorac Cardiovasc Surg 108:321–328PubMedGoogle Scholar
  24. 24.
    Detterbeck FC, DeCamp MM Jr, Kohman LJ, Silvestri GA (2003) Lung cancer. Invasive staging: the guidelines. Chest 123:167S–175SPubMedCrossRefGoogle Scholar
  25. 25.
    Passlick B (2003) Initial surgical staging of lung cancer. Lung Cancer 42:S21–S25PubMedCrossRefGoogle Scholar
  26. 26.
    Sebastian-Quetglas F, Molins L, Baldo X, Buitrago J, Vidal G (2003) Clinical value of video-assisted thoracoscopy for preoperative staging of non-small cell lung cancer: a prospective study of 105 patients. Lung Cancer 42:297–301PubMedCrossRefGoogle Scholar
  27. 27.
    Ishida T, Tateishi M, Kaneko S, Sugimachi K (1990) Surgical treatment of patients with non-small cell lung cancer and mediastinal lymph node involvement. J Surg Oncol 43:161–166PubMedCrossRefGoogle Scholar
  28. 28.
    Crippa F, Leutner M, Belli F, Gallino F, Greco M, Pilotti S, Cascinelli N, Bombardieri E (2000) Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanoma. J Nucl Med 41:1491–1494PubMedGoogle Scholar
  29. 29.
    Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T (1992) Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 33:1972–1980PubMedGoogle Scholar
  30. 30.
    Kubota R, Kubota K, Yamada S, Tada M, Ido T, Tamahashi N (1994) Active and passive mechanisms of [fluorine-18] fluorodeoxyglucose uptake by proliferating and prenecrotic cancer cells in vivo: a microautoradiographic study. J Nucl Med 35:1067–1075PubMedGoogle Scholar
  31. 31.
    Deichen JT, Prante O, Gack M, Schmiedehausen K, Kuwert T (2003) Uptake of [18F]fluorodeoxyglucose in human monocytemacrophages in vitro. Eur J Nucl Med Mol Imaging 30:267–273PubMedGoogle Scholar
  32. 32.
    Ohtsuki Y, Uomoto M, Hachisuka Y, Kato M, Iguchi M, Lee GH, Furihata M (2008) A rare case of coexistence of pulmonary adenocarcinoma with Langerhans’ cell histiocytosis. Med Mol Morphol 41:175–178PubMedCrossRefGoogle Scholar
  33. 33.
    Genereux GP, Howie JL (1984) Normal mediastinal lymph node size and number: CT and anatomic study. AJR Am J Roentgenol 142:1095–1100PubMedGoogle Scholar
  34. 34.
    Kiyono K, Sone S, Sakai F, Imai Y, Watanabe T, Izuno I, Oguchi M, Kawai T, Shigematsu H, Watanabe M (1988) The number and size of normal mediastinal lymph nodes: a postmortem study. AJR Am J Roentgenol 150:771–776PubMedGoogle Scholar
  35. 35.
    Suzuki K, Nagai K, Yoshida J, Nishimura M, Takahashi K, Nishiwaki Y (1999) Clinical predictors of N2 disease in the setting of a negative computed tomographic scan in patients with lung cancer. J Thorac Cardiovasc Surg 117:593–598PubMedCrossRefGoogle Scholar
  36. 36.
    Takamochi K, Nagai K, Suzuki K, Yoshida J, Ohde Y, Nishiwaki Y (2000) Clinical predictors of N2 disease in non-small cell lung cancer. Chest 117:1577–1582PubMedCrossRefGoogle Scholar

Copyright information

© The Japanese Society for Clinical Molecular Morphology 2009

Authors and Affiliations

  • Hajimu Gotoh
    • 1
    • 2
  • Naoki Kanomata
    • 1
    • 3
  • Masahiro Yoshimura
    • 4
  • Yoshiharu Ohno
    • 2
  • Takuya Moriya
    • 3
  • Chiho Ohbayashi
    • 1
  1. 1.Surgical Pathology DivisionKobe University HospitalKobeJapan
  2. 2.Department of RadiologyKobe University Graduate School of MedicineKobeJapan
  3. 3.Department of PathologyKawasaki Medical SchoolKurashiki, OkayamaJapan
  4. 4.Department of Cardiovascular, Thoracic and Pediatric SurgeryKobe University Graduate School of MedicineKobeJapan

Personalised recommendations